Simplifying IT Therapy: A Solution to the Opioid Crisis

8:00 AM - 5:00 PM Thursday, January 17

IT Therapy is a mature therapy that is currently indicated for chronic pain and severe spasticity. This course will provide novice practitioners of this therapy a framework to introduce IT therapy into their clinical practice.

CME Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Congress of Neurological Surgeons (CNS) and the North American Neuromodulation Society. The CNS is accredited by ACCME to provide continuing medical education for physicians.

The CNS designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Explain the nature of the various phases of IT therapy, including selection, trial, implant, and continued therapy.
  • Discuss the basics of intrathecal pharmacology.
  • Describe the special concerns for specific populations, such as pediatrics, cancer patients, and the elderly, relative to IT delivery.
  • Review the financial aspects of IT delivery.

Registration Rates:

Registration on or Before November 2, 2018:
Member: $135
Non-Member: $195

Registration After November 2, 2018:
Member: $185
Non-Member: $235

Patient Selection

Michael F. Saulino, MD, PhD

Psychological Evaluation

W. Michael Hooten, MD

Trialing for Intrathecal Delivery Including Patient Preparation

Jay S. Grider, DO PhD MBA

Implantation

Jay S. Grider, DO PhD

Troubleshooting Intrathecal Delivery Systems

Michael F. Saulino, MD PhD

Long-Term Management and Concerns in the Elderly

Salim M. Hayek, MD, PhD

Basic Intrathecal Pharmacology

Tony L. Yaksh, PhD

Concerns in the Cancer Patient

Ann C. Shah, MD

Management of Challenging Cases Addressing Infectious and Anticoagulation Concerns

Erik Shaw, DO

Future Direction in IT Therapy - Drugs

Tony L. Yaksh, PhD

Future Direction in IT Therapy - Devices

Michael F. Saulino, MD, PhD

Coding/Billing and Financial Aspects

Mehul J. Desai, MD, MPH

Faculty subject to change.